ATE205221T1 - Zusammensetzungen und verfahren zur detektion und behandlung des erworbenen immun-defizienz- syndroms - Google Patents

Zusammensetzungen und verfahren zur detektion und behandlung des erworbenen immun-defizienz- syndroms

Info

Publication number
ATE205221T1
ATE205221T1 AT96920118T AT96920118T ATE205221T1 AT E205221 T1 ATE205221 T1 AT E205221T1 AT 96920118 T AT96920118 T AT 96920118T AT 96920118 T AT96920118 T AT 96920118T AT E205221 T1 ATE205221 T1 AT E205221T1
Authority
AT
Austria
Prior art keywords
compositions
methods
detecting
immune deficiency
deficiency syndrome
Prior art date
Application number
AT96920118T
Other languages
English (en)
Inventor
Harry P Zhabilov
Original Assignee
Tomson U S A Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomson U S A Ltd filed Critical Tomson U S A Ltd
Priority claimed from PCT/US1996/006079 external-priority patent/WO1996034886A1/en
Application granted granted Critical
Publication of ATE205221T1 publication Critical patent/ATE205221T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96920118T 1995-05-01 1996-05-01 Zusammensetzungen und verfahren zur detektion und behandlung des erworbenen immun-defizienz- syndroms ATE205221T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43188395A 1995-05-01 1995-05-01
US48554895A 1995-06-07 1995-06-07
US64193696A 1996-05-01 1996-05-01
PCT/US1996/006079 WO1996034886A1 (en) 1995-05-01 1996-05-01 Compositions and methods for detecting and treating acquired immunodeficiency syndrome

Publications (1)

Publication Number Publication Date
ATE205221T1 true ATE205221T1 (de) 2001-09-15

Family

ID=27411755

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96920118T ATE205221T1 (de) 1995-05-01 1996-05-01 Zusammensetzungen und verfahren zur detektion und behandlung des erworbenen immun-defizienz- syndroms

Country Status (10)

Country Link
EP (2) EP0826003B1 (de)
CN (1) CN1221568C (de)
AT (1) ATE205221T1 (de)
BG (1) BG64056B1 (de)
CA (1) CA2220347C (de)
DE (1) DE69615015T2 (de)
DK (1) DK0826003T3 (de)
EA (1) EA001100B1 (de)
ES (1) ES2163028T3 (de)
IL (1) IL118103A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008057479A1 (de) 2008-11-14 2010-05-20 Bernhard, Stefan, Dr. Vorrichtung und Verfahren zur Stärkung des Immunsystems durch Langzeitstimulation der Thymusdrüse
CN112782398A (zh) * 2020-12-28 2021-05-11 重庆生命知源科技有限公司 一种微量蛋白免疫印迹检测方法
CN119746205B (zh) * 2024-12-25 2025-09-30 深圳市浩然盈科通讯科技有限公司 一种智能输液控制方法、系统、存储介质及程序产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) * 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms
US4818763A (en) * 1984-01-12 1989-04-04 Volker Rusch Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes
WO1989005455A1 (en) * 1987-12-02 1989-06-15 The Regents Of The University Of California Aids-related anti-t-cell antibody test
GB9209874D0 (en) * 1992-05-07 1992-06-24 Ml Lab Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
DE69615015T2 (de) 2002-06-27
EP0826003B1 (de) 2001-09-05
DE69615015D1 (de) 2001-10-11
CN1221568C (zh) 2005-10-05
BG102083A (en) 1998-10-30
BG64056B1 (bg) 2003-11-28
CN1189839A (zh) 1998-08-05
EP1104770A2 (de) 2001-06-06
CA2220347A1 (en) 1996-11-07
IL118103A0 (en) 1997-03-18
HK1009457A1 (en) 1999-06-04
EP0826003A1 (de) 1998-03-04
DK0826003T3 (da) 2001-11-26
EA001100B1 (ru) 2000-10-30
CA2220347C (en) 2003-03-18
EA199700353A1 (ru) 1998-04-30
EP1104770A3 (de) 2001-06-27
ES2163028T3 (es) 2002-01-16
IL118103A (en) 2000-02-29

Similar Documents

Publication Publication Date Title
Nara et al. Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies
CY1106207T1 (el) Αντιιικα παραγωγα νουκλεοζιτων
ATE418562T1 (de) Ctl epitope des epstein-barr virus
EP0675904A4 (de) Humane neutralisierende monoklonale antikörper gegen den die immunschwäche auslösenden virus aus mensch.
GR1000489B (el) Αλληλουχιες dna,μορια ανασυνδιασμενου dna και μεθοδοι για την παραγωγη διαλυτων τ4 πρωτεινων.
IL118625A0 (en) Anti HBV antibodies
GR3022248T3 (en) Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses
WO2002068654A3 (es) Poxvirus recombinantes para proteinas quimericas del virus de la inmunodeficiencia humana
CA2218561A1 (en) Compounds and methods of use to treat infectious diseases
DE69615015D1 (de) Zusammensetzungen und verfahren zur detektion und behandlung des erworbenen immun-defizienz-syndroms
WO2005111079A3 (en) Hiv vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-hiv-1 antibodies against the membrane proximal domain of hiv gp41
BR9608837A (pt) "composição obtida de células para detectar uma infecção por vìrus da imunodeficiência humana, aparelho, kit e métodos para sua detecção, purificação da proteìna e sua obtenção e tratamento do ser humano"
Steimer et al. HIV-1 neutralization directed to epitopes other than linear V3 determinants
ATE284709T1 (de) Virale chimären aus caev und hiv-1 genetischen elementen
KR100871455B1 (ko) Ｈｉｖ 바이러스에 대한 천연 항체
EP0491888A4 (en) Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
EP0247873A3 (de) Bacteriocine und Zubereitungen derselben für die antivirale Behandlung
FR2678835B1 (fr) Composition a base de buis pour le traitement de l'infection par le vih (virus de l'immunodefiscience humaine).
WO2002026253A1 (en) A vaccine for acids and its preparation and use
Koprowski et al. Anti-idiotype vaccines against viral infections
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer
Osterhaus et al. Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections
IE894005L (en) Medication for the treatment or prevention of hiv virus¹infection through passive immunization and processes for its¹preparation
Osterhaus Development of a vaccine against AIDS: state of the art.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee